Ubs Asset Management Americas Inc Vir Biotechnology, Inc. Transaction History

Ubs Asset Management Americas Inc

  • $381 Billion
  • Q3 2024

A detailed history of Ubs Asset Management Americas Inc transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 140,371 shares of VIR stock, worth $999,441. This represents 0.0% of its overall portfolio holdings.

Number of Shares
140,371
Previous 170,559 17.7%
Holding current value
$999,441
Previous $1.52 Million 30.72%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$7.26 - $10.7 $219,164 - $323,011
-30,188 Reduced 17.7%
140,371 $1.05 Million
Q2 2024

Aug 13, 2024
BUY
$7.63 - $12.66 $598,955 - $993,810
78,500 Added 85.27%
170,559 $1.52 Million
Q4 2023

Feb 14, 2024
BUY
$7.76 - $10.29 $90,365 - $119,827
11,645 Added 14.48%
92,059 $926,000
Q3 2023

Nov 13, 2023
SELL
$9.14 - $24.62 $80,697 - $217,369
-8,829 Reduced 9.89%
80,414 $753,000
Q1 2023

May 15, 2023
BUY
$22.26 - $30.85 $389,505 - $539,813
17,498 Added 24.39%
89,243 $2.08 Million
Q4 2022

Feb 14, 2023
BUY
$19.96 - $28.22 $169,939 - $240,265
8,514 Added 13.46%
71,745 $1.82 Million
Q3 2022

Nov 14, 2022
SELL
$18.26 - $31.1 $280,017 - $476,918
-15,335 Reduced 19.52%
63,231 $1.22 Million
Q2 2022

Aug 12, 2022
BUY
$19.08 - $26.7 $211,520 - $295,996
11,086 Added 16.43%
78,566 $2 Million
Q1 2022

May 16, 2022
BUY
$21.19 - $40.01 $51,661 - $97,544
2,438 Added 3.75%
67,480 $1.74 Million
Q4 2021

Feb 14, 2022
BUY
$30.97 - $54.03 $40,973 - $71,481
1,323 Added 2.08%
65,042 $2.72 Million
Q3 2021

Nov 15, 2021
BUY
$34.9 - $54.54 $19,160 - $29,942
549 Added 0.87%
63,719 $2.77 Million
Q2 2021

Aug 16, 2021
BUY
$38.75 - $51.0 $2.06 Million - $2.71 Million
53,111 Added 527.99%
63,170 $2.99 Million
Q4 2020

Mar 01, 2021
SELL
$25.51 - $43.38 $3.02 Million - $5.13 Million
-118,199 Reduced 92.16%
10,059 $269,000
Q3 2020

Nov 13, 2020
SELL
$28.28 - $53.6 $610,819 - $1.16 Million
-21,599 Reduced 14.41%
128,258 $4.4 Million
Q2 2020

Aug 14, 2020
BUY
$27.89 - $47.86 $4.18 Million - $7.17 Million
149,857 New
149,857 $6.14 Million

Others Institutions Holding VIR

# of Institutions
219
Shares Held
87.4M
Call Options Held
127K
Put Options Held
1.19M
View Full List

About Vir Biotechnology, Inc.

VIR Quotes by TradingView
  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $944M
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email